Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients

NCT ID: NCT00337038

Last Updated: 2012-06-22

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: EARLY_PHASE1
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-06-30
• Study Completion Date: 2010-07-31

Brief Summary

Our aim is to examine the influence of blood pressure and glycemic control together with N-acetylcystein utilization on the endothelia function of hypertensive diabetic patient.The study population will include 50 diabetic patient with uncontrolled hypertention that will be recruited from the Hypertension Clinic of Soroka University Medical Center.

Conditions

Hypertension; Diabetes Mellitus Type 2

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Interventions

N-acetylcystein(drug)

p.O t.Siran 200mg x1 during one weak

Intervention Type: DRUG

Other Intervention Names

siran

Eligibility Criteria

Inclusion Criteria

• Diabetic patients with uncontrolled hypertension that will be recruited from the Hypertension Clinic of Soroka University Medical Center

Exclusion Criteria

• Pregnancy,secondary hypertention,malignancy or other serious illness

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Soroka University Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Valentin Yurkevich

Dr Yurkevich

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ester Paran, MD

Role: PRINCIPAL_INVESTIGATOR

Hypertension Clinic of Soroka University Medical Center

Ester Paran, MD

Role: PRINCIPAL_INVESTIGATOR

Soroka University Medical Center

Other Identifiers

sor431706ctil

Identifier Type: -

Identifier Source: org_study_id